Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients

  • STATUS
    Recruiting
  • days left to enroll
    89
  • participants needed
    90
  • sponsor
    Assiut University
Updated on 11 November 2021
Accepts healthy volunteers

Summary

The investigators thought to explore arrhythmias outcome - hidden arrhythmias, ECG features: Tp-Te interval and Tp-Te/QTc ratio, fQRS among patients with coronary artery ectasia as compared to normal coronary artery patients.

Description

All patients will be subjected to:

  1. Full history taking:
    • Including age, sex, history of DM, HTN, dyslipidemia and Body surface area.
  2. Holter monitoring for 24 hours:
    • Heart rate variability
    • Hidden arrhythmias
    • Hidden ischemia by monitoring ST segment changes
  3. Twelve lead ECG:
    • fQRS in baseline ECG
    • QT dispersion.
    • Tp-Te interval and Tp-Te/QTc ratio
    • Tp-Te dispersion

Details
Condition Coronary artery aneurysm, Coronary Artery Ectasia
Treatment Holter, ECG
Clinical Study IdentifierNCT05106530
SponsorAssiut University
Last Modified on11 November 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Subjects with suspected CAD who are referred for elective coronary angiography and/or interventions

Exclusion Criteria

Patients with a history of cardiomyopathy and myocardial infarction (MI), left ventricular hypertrophy (LVH), pathological Q wave on ECG, typical left bundle block or right bundle block, incomplete right bundle block, or paced rhythm on ECG
Patients with severe renal impairment
Post CABG patients
Patients of acute coronary syndrome
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note